Stefanie J. Fogel is a trial lawyer in DLA Piper's Litigation practice group who focuses on commercial litigation, product liability litigation, and regulatory and code compliance. She represents national and international manufacturers of equipment chemical products, bio-technology detection devices, pharmaceutical products and a variety of consumer products. She serves as national coordinating counsel for multiple clients in the area of toxic torts, consumer fraud, and product liability matters, and represents them against individual, multi-district and class action claims. She has developed a multidisciplinary crisis management team to quickly and effectively address issues arising out of recalls, natural disasters, equipment failure, and environmental leaks and spills.

Ms. Fogel has successfully defended cases to trial in both state and federal courts across the country. She has lectured across the country on subjects relating to evidentiary, in-house witness, expert witness and civil practice litigation issues.

A significant amount of her practice is also focused on litigation preparedness, particularly with respect to corporate compliance issues, process management, records and information management (RIM), privacy and e-discovery. She has developed protocols for the implementation of national and international document retention schedules, records management programs, e-discovery strategic plans, and ISO auditing. Ms. Fogel has lectured extensively on RIM and e-discovery requirements and is currently advising multiple clients on developing best practices for addressing obligations under developing case law and the Federal Rules. Ms. Fogel is also member of DLA Piper's Electronic Discovery Readiness and Response Group.

She has been selected to serve on DLA Piper's governing Policy Committee and the Hiring Committee, and is the current Litigation Advisor Coordinator. Ms. Fogel is also proud to be the co-founder and co-chair for DLA Piper’s National Leadership Alliance for Women (LAW) Program.

Ms. Fogel is admitted to practice in Pennsylvania and New York and has been admitted in various other states pro hac vice. A Wharton School graduate, Ms. Fogel was a commercial real estate financial analyst concerned with urban development before coming to DLA Piper.

Significant Matters

• Served as in-house consultant for an eight-month period to an international technology/communications company in order to establish a protocol for litigation crisis management and regulatory reporting. Instituted quality assurance policies and procedures as part of litigation prevention strategy.
• Representation of a biotechnology company in assessment of potential liability and avoidance mechanisms in the development and manufacture and distribution of pathogen detection devices for governmental and civilian use.
• Representation of a national pharmaceutical company in litigation arising out of the distribution of federally approved drugs alleged to have resulted in serious injury and death across the country.
• Representation of a national oil and gas company in crisis response and subsequent litigation resulting from a toxic release.
• Representation of a national chemical corporation involved in a significant toxic chemical release in crisis response and subsequent class actions as well as multimillion-dollar claims litigation.
• National representation of a national motorcycle manufacturers in toxic tort litigation including the development of a national defense strategy, in-house witnesses identification and preparation, discovery coordination and trial.
• National representation of national heavy industrial equipment manufacturers in toxic tort litigation to include the development of a national defense strategy, in-house witnesses identification and preparation, discovery coordination and trial.
• Representation of international children's products manufacturers in car seat, swing and stroller litigation to include development of in-house witnesses and experts for national litigation platform.
• Representation of international motorcycle manufacturers in products liability litigation across the country to include the development of a national defense strategy, in-house witness identification and preparation, discovery coordination and trial.
• Representation of an international consumer product manufacturer in the development of a coordinated e-discovery protocol.
• Representation of an international health insurance company in the development of a coordinated document management program as well as an e-discovery protocol.
• Representation of major package carrier in products liability litigation to include all facets of trial preparation.
• Representation of an elevator and escalator company in products liability litigation to include all facets of trial preparation.